The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9907644 B1

PDF
Full Text
Expired
Date of Patent:
Mar. 06, 2018

Filed:

Jun. 02, 2017
Applicant:

Boston Scientific Scimed, Inc., Maple Grove, MN (US);

Inventors:

John Allen Hingston, Framingham, MA (US);

Matthew B. Hollyer, Williamstown, VT (US);

Assignee:

BOSTON SCIENTIFIC SCIMED, INC., Maple Grove, MN (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 2/90 (2013.01); A61F 2/07 (2013.01); A61F 2/95 (2013.01); A61L 31/10 (2006.01); A61L 31/14 (2006.01); A61L 31/04 (2006.01); A61F 2/86 (2013.01); A61F 2/04 (2013.01); A61F 2/00 (2006.01);
U.S. Cl.
CPC ...
A61F 2/07 (2013.01); A61F 2/0077 (2013.01); A61F 2/04 (2013.01); A61F 2/86 (2013.01); A61F 2/90 (2013.01); A61F 2/95 (2013.01); A61L 31/048 (2013.01); A61L 31/10 (2013.01); A61L 31/148 (2013.01); A61F 2002/009 (2013.01); A61F 2002/044 (2013.01); A61F 2002/072 (2013.01); A61F 2002/9528 (2013.01); A61F 2210/0004 (2013.01); A61F 2250/003 (2013.01); A61F 2250/0031 (2013.01); A61F 2250/0039 (2013.01); A61F 2250/0041 (2013.01); A61F 2250/0059 (2013.01); A61L 2420/00 (2013.01);
Abstract

A medical product comprises a biodegradable filament and a non-biodegradeable coating. The biodegradable filament forms a stent body having a first end portion, a middle portion, and a second end portion opposite the first end portion. The middle portion extends between the first and second end portions. The non-biodegradeable coating encapsulates the at least one biodegradable filament along the middle portion of the stent body. The non-biodegradeable coating forms a barrier such that the non-biodegradeable coating prevents degradation of the at least one biodegradable filament along the middle portion. The first and second end portions are uncoated. After implantation, the end portions of the stent may biodegrade. The middle portion will not biodegrade due to its encapsulation by the non-biodegradeable coating.


Find Patent Forward Citations

Loading…